Paper19902987
Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.
Zhou SF. Clin Pharmacokinet, 2009. Cited by 277 papers, by iCite.
Cite this record
ConductScience Library. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. Papers, record 19902987. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19902987
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytochrome P-450 CYP2D6 | Major topic |
| Mental Disorders | Major topic |
| Polymorphism, Genetic | Major topic |
| Psychotropic Drugs | Major topic |
| Analgesics, Opioid | |
| Animals | |
| Antiemetics | |
| Genotype | |
| Histamine Antagonists | |
| Humans | |
| Muscarinic Antagonists | |
| Phenotype | |
| Selective Estrogen Receptor Modulators |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02624167 | A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia | Background |
Source ClinicalTrials.gov
References453
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18382661 | Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample. | PLoS One | 2008 | https://conductscience.org/library/papers/18382661 | PubMed |
| 2 | 11907488 | Low daily 10-mg and 20-mg doses of fluvoxamine inhibit the metabolism of both caffeine (cytochrome P4501A2) and omeprazole (cytochrome P4502C19). | Clin Pharmacol Ther | 2002 | https://conductscience.org/library/papers/11907488 | PubMed |
| 3 | 1686692 | N(+)-glucuronidation of aliphatic tertiary amines, a general phenomenon in the metabolism of H1-antihistamines in humans. | Xenobiotica | 1991 | https://conductscience.org/library/papers/1686692 | PubMed |
| 4 | 18294088 | Latino versus Caucasian response to atomoxetine in attention-deficit/hyperactivity disorder. | J Child Adolesc Psychopharmacol | 2008 | https://conductscience.org/library/papers/18294088 | PubMed |
| 5 | 14717619 | Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder. | Drugs | 2004 | https://conductscience.org/library/papers/14717619 | PubMed |
| 6 | 11133003 | CYP3A is responsible for N-dealkylation of haloperidol and bromperidol and oxidation of their reduced forms by human liver microsomes. | Life Sci | 2000 | https://conductscience.org/library/papers/11133003 | PubMed |
| 7 | 10982205 | Risperidone metabolism and the impact of being a cytochrome P450 2D6 ultrarapid metabolizer. | J Clin Psychiatry | 2000 | https://conductscience.org/library/papers/10982205 | PubMed |
| 8 | 17202571 | Safety of aripiprazole: high serum levels in a CYP2D6 mutated patient. | Am J Psychiatry | 2007 | https://conductscience.org/library/papers/17202571 | PubMed |
| 9 | 9143866 | Different effects of inhibitors on the O- and N-demethylation of codeine in human liver microsomes. | Eur J Clin Pharmacol | 1997 | https://conductscience.org/library/papers/9143866 | PubMed |
| 10 | 9352573 | Genetically deficient CYP2D6 metabolism provides protection against oral opiate dependence. | Pharmacogenetics | 1997 | https://conductscience.org/library/papers/9352573 | PubMed |
| 11 | 15482390 | Population pharmacokinetic modelling of tramadol with application of the NPEM algorithms. | J Clin Pharm Ther | 2004 | https://conductscience.org/library/papers/15482390 | PubMed |
| 12 | 17725248 | Lack of influence of CYP2D6 genotype on the clearance of (R)-, (S)- and racemic-methadone. | Int J Clin Pharmacol Ther | 2007 | https://conductscience.org/library/papers/17725248 | PubMed |
| 13 | 13773933 | Drug-induced extrapyramidal reactions. Treatment with diphenhydramine hydrochloride and dihydroxyphenylalanine. | JAMA | 1961 | https://conductscience.org/library/papers/13773933 | PubMed |
| 14 | 8093319 | Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine. | Lancet | 1993 | https://conductscience.org/library/papers/8093319 | PubMed |
| 15 | 15168101 | Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting. | Eur J Clin Pharmacol | 2004 | https://conductscience.org/library/papers/15168101 | PubMed |
| 16 | 6120818 | Demethylation and hydroxylation of amitriptyline, nortriptyline, and 10-hydroxyamitriptyline in human liver microsomes. | Drug Metab Dispos | 1981 | https://conductscience.org/library/papers/6120818 | PubMed |
| 17 | 321205 | Doxepin up-to-date: a review of its pharmacological properties and therapeutic efficacy with particular reference to depression. | Drugs | 1977 | https://conductscience.org/library/papers/321205 | PubMed |
| 18 | 16236141 | Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetine. | Basic Clin Pharmacol Toxicol | 2005 | https://conductscience.org/library/papers/16236141 | PubMed |
| 19 | 15987423 | Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients. | Breast Cancer Res | 2005 | https://conductscience.org/library/papers/15987423 | PubMed |
| 20 | 8013282 | The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron. | Drug Metab Dispos | 1994 | https://conductscience.org/library/papers/8013282 | PubMed |
Cited by137
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 277 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42792193 | CYP2D6 as an Emerging Endogenous Oxidative Stress Modulator in Cardiovascular Disease: Genetic, Pharmacological, and Redox Perspectives. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42792193 | PubMed |
| 42291620 | Investigation of Pharmacogenomic Variants in the CYP (P450) Family in Native American Populations of the Brazilian Amazon. | Int J Genomics | 2026 | https://conductscience.org/library/papers/42291620 | PubMed |
| 41816596 | A nine-gene nicotine-metabolism signature predicts prognosis and characterizes the immune landscape in colon adenocarcinoma. | J Gastrointest Oncol | 2026 | https://conductscience.org/library/papers/41816596 | PubMed |
| 41460788 | Development of a CYP2D6-enhanced HepaRG cell model with improved CYP2D6 metabolic capacity. | PLoS One | 2025 | https://conductscience.org/library/papers/41460788 | PubMed |
| 40847116 | The impact of the number of non-opioid psychotropic medications and their co-exposures during pregnancy on short-term outcomes in full-term neonates. | Sci Rep | 2025 | https://conductscience.org/library/papers/40847116 | PubMed |
| 40191458 | In silico approaches to identify novel anti-diabetic type 2 agents against dipeptidyl peptidase IV from isoxazole derivatives of usnic acid. | 3 Biotech | 2025 | https://conductscience.org/library/papers/40191458 | PubMed |
| 40188031 | The augmentative efficacy of second-generation anti-psychotics (SGA) to anti-depressants in treating treatment-resistant depression: a network meta-regression analysis. | BMC Psychiatry | 2025 | https://conductscience.org/library/papers/40188031 | PubMed |
| 40006546 | Physiologically Based Pharmacokinetic Model of CYP2D6 Associated Interaction Between Venlafaxine and Strong Inhibitor Bupropion-The Influence of Age-Relevant Changes and Inhibitory Dose to Classify Therapeutical Success and Harm. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40006546 | PubMed |
| 39899439 | CYP2D6 genotype and associated 5-HT3 receptor antagonist outcomes: A systematic review and meta-analysis. | Clin Transl Sci | 2025 | https://conductscience.org/library/papers/39899439 | PubMed |
| 39832962 | Effect of a multimodal analgesia strategy on remifentanil daily consumption in mechanically ventilated adult ICU patients: study protocol for a randomised, placebo-controlled, double-blind, parallel-group clinical trial. | BMJ Open | 2025 | https://conductscience.org/library/papers/39832962 | PubMed |
| 39774017 | High-coverage whole-genome sequencing of a Jakun individual from the "Orang Asli" Proto-Malay subtribe from Peninsular Malaysia. | Hum Genome Var | 2025 | https://conductscience.org/library/papers/39774017 | PubMed |
| 39469676 | Estrogenic post-menopausal anti-osteoporotic mechanism of Achyranthes aspera L.: Phytochemicals and network pharmacology approaches. | Heliyon | 2024 | https://conductscience.org/library/papers/39469676 | PubMed |
| 39201627 | Pharmacogenetic Approach to Tramadol Use in the Arab Population. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39201627 | PubMed |
| 38797832 | Association of CYP2D6 and CYP2C19 metabolizer status with switching and discontinuing antidepressant drugs: an exploratory study. | BMC Psychiatry | 2024 | https://conductscience.org/library/papers/38797832 | PubMed |
| 38765225 | An Effective Method to Facilitate Personalized and Precise Medicine for Schizophrenia Treatment Based on Pharmacogenomics. | Psychiatry Clin Psychopharmacol | 2021 | https://conductscience.org/library/papers/38765225 | PubMed |
| 37993281 | Genotype-guided new approach for dose optimisation of hydroxychloroquine administration in Chinese patients with SLE. | Lupus Sci Med | 2023 | https://conductscience.org/library/papers/37993281 | PubMed |
| 37719112 | Effect of apatinib on the pharmacokinetics of tramadol and O-desmethyltramadol in rats. | PeerJ | 2023 | https://conductscience.org/library/papers/37719112 | PubMed |
| 37670118 | Multivariate QSAR, similarity search and ADMET studies based in a set of methylamine derivatives described as dopamine transporter inhibitors. | Mol Divers | 2024 | https://conductscience.org/library/papers/37670118 | PubMed |
| 37568345 | How to Choose the Optimal Starting Dose of Clomiphene Citrate (50 or 100 mg per Day) for a First Cycle of Ovulation Induction in Anovulatory PCOS Women? | J Clin Med | 2023 | https://conductscience.org/library/papers/37568345 | PubMed |
| 37554850 | Tramadol poisoning and its management and complications: a scoping review. | Ann Med Surg (Lond) | 2023 | https://conductscience.org/library/papers/37554850 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CYP2D6 | 1565 | PubTator's text mining | https://conductscience.org/library/genes/1565 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19902987
GET https://conductscience.org/api/papers/v1/19902987/references?page=2